Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts

Benjamin E. Hippen, Angelo M DeMattos, William J. Cook, Clifton E. Kew, Robert S. Gaston

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

We undertook a study to ascertain the relationship between the presence of CD20-positive B-lymphocytes in renal allografts undergoing acute cellular rejection and graft survival. We identified 27 patients transplanted between January 1, 1998 and December 31, 2001, with biopsy-proven Banff 1-A or Banff 1-B rejection in the first year after transplantation, and stained the specimens for CD20 and C4d. At least 4 years of follow-up data were available for each patient studied. Six patients had CD20-positive B-cell clusters in the interstitium, and 21 patients were negative for CD20 infiltrates. The CD20-positive group was significantly more likely to have steroid-resistant rejection and reduced graft survival compared to CD20-negative controls. This study supports prospective identification of CD20-positive B-cell clusters in biopsy-proven rejection and offers a therapeutic rationale for a trial of monoclonal anti-CD20 antibody in such patients.

Original languageEnglish (US)
Pages (from-to)2248-2252
Number of pages5
JournalAmerican Journal of Transplantation
Volume5
Issue number9
DOIs
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Allografts
Kidney
B-Lymphocytes
Graft Survival
Biopsy
Anti-Idiotypic Antibodies
Transplantation
Steroids
Monoclonal Antibodies
Prospective Studies
Therapeutics

Keywords

  • B-cells
  • Biopsy
  • Graft survival
  • Kidney transplantation
  • Rejection

ASJC Scopus subject areas

  • Immunology

Cite this

Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. / Hippen, Benjamin E.; DeMattos, Angelo M; Cook, William J.; Kew, Clifton E.; Gaston, Robert S.

In: American Journal of Transplantation, Vol. 5, No. 9, 09.2005, p. 2248-2252.

Research output: Contribution to journalArticle

Hippen, Benjamin E. ; DeMattos, Angelo M ; Cook, William J. ; Kew, Clifton E. ; Gaston, Robert S. / Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. In: American Journal of Transplantation. 2005 ; Vol. 5, No. 9. pp. 2248-2252.
@article{60fcbcb540474a33b84edea70af3207f,
title = "Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts",
abstract = "We undertook a study to ascertain the relationship between the presence of CD20-positive B-lymphocytes in renal allografts undergoing acute cellular rejection and graft survival. We identified 27 patients transplanted between January 1, 1998 and December 31, 2001, with biopsy-proven Banff 1-A or Banff 1-B rejection in the first year after transplantation, and stained the specimens for CD20 and C4d. At least 4 years of follow-up data were available for each patient studied. Six patients had CD20-positive B-cell clusters in the interstitium, and 21 patients were negative for CD20 infiltrates. The CD20-positive group was significantly more likely to have steroid-resistant rejection and reduced graft survival compared to CD20-negative controls. This study supports prospective identification of CD20-positive B-cell clusters in biopsy-proven rejection and offers a therapeutic rationale for a trial of monoclonal anti-CD20 antibody in such patients.",
keywords = "B-cells, Biopsy, Graft survival, Kidney transplantation, Rejection",
author = "Hippen, {Benjamin E.} and DeMattos, {Angelo M} and Cook, {William J.} and Kew, {Clifton E.} and Gaston, {Robert S.}",
year = "2005",
month = "9",
doi = "10.1111/j.1600-6143.2005.01009.x",
language = "English (US)",
volume = "5",
pages = "2248--2252",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts

AU - Hippen, Benjamin E.

AU - DeMattos, Angelo M

AU - Cook, William J.

AU - Kew, Clifton E.

AU - Gaston, Robert S.

PY - 2005/9

Y1 - 2005/9

N2 - We undertook a study to ascertain the relationship between the presence of CD20-positive B-lymphocytes in renal allografts undergoing acute cellular rejection and graft survival. We identified 27 patients transplanted between January 1, 1998 and December 31, 2001, with biopsy-proven Banff 1-A or Banff 1-B rejection in the first year after transplantation, and stained the specimens for CD20 and C4d. At least 4 years of follow-up data were available for each patient studied. Six patients had CD20-positive B-cell clusters in the interstitium, and 21 patients were negative for CD20 infiltrates. The CD20-positive group was significantly more likely to have steroid-resistant rejection and reduced graft survival compared to CD20-negative controls. This study supports prospective identification of CD20-positive B-cell clusters in biopsy-proven rejection and offers a therapeutic rationale for a trial of monoclonal anti-CD20 antibody in such patients.

AB - We undertook a study to ascertain the relationship between the presence of CD20-positive B-lymphocytes in renal allografts undergoing acute cellular rejection and graft survival. We identified 27 patients transplanted between January 1, 1998 and December 31, 2001, with biopsy-proven Banff 1-A or Banff 1-B rejection in the first year after transplantation, and stained the specimens for CD20 and C4d. At least 4 years of follow-up data were available for each patient studied. Six patients had CD20-positive B-cell clusters in the interstitium, and 21 patients were negative for CD20 infiltrates. The CD20-positive group was significantly more likely to have steroid-resistant rejection and reduced graft survival compared to CD20-negative controls. This study supports prospective identification of CD20-positive B-cell clusters in biopsy-proven rejection and offers a therapeutic rationale for a trial of monoclonal anti-CD20 antibody in such patients.

KW - B-cells

KW - Biopsy

KW - Graft survival

KW - Kidney transplantation

KW - Rejection

UR - http://www.scopus.com/inward/record.url?scp=27844510762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27844510762&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2005.01009.x

DO - 10.1111/j.1600-6143.2005.01009.x

M3 - Article

C2 - 16095505

AN - SCOPUS:27844510762

VL - 5

SP - 2248

EP - 2252

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 9

ER -